They also presented updates on vaccine effectiveness.
https://www.fda.gov/media/179140/download
45% VE for symptomatic infection, 42% VE for hospitalization. After 120 days only 16% VE for hospitalization. Interestingly VE for infection was better after 120 days at 47%.